株式会社M&A総研ホールディングス Stock: price and insider trades · Japan
株式会社M&A総研ホールディングス: what insiders have been doing
株式会社M&A総研ホールディングス is a Health Care company. Its directors and officers file their transactions with EDINET (Japan FSA). Between 10 November 2025 and 10 November 2026, 1 insider published 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 3,423 companies) published 3 filings over the same period, against 4 filings here.
No insider has bought 株式会社M&A総研ホールディングス shares on the open market in the past twelve months. Filings reach the EDINET (Japan FSA) feed a median of 6 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.
Financial data
· cache
- ShareXTKSEDINET:S100XEVE
- ShareXTKSEDINET:S100XBSI
- ShareXTKSEDINET:S100X8J8
- ShareXTKSEDINET:S100X5T5
- ShareXTKSEDINET:S100X00N
- ShareXTKSEDINET:S100WTI3
- ShareXTKSEDINET:S100VC9H
- ShareXTKSEDINET:S100V6G5
- ShareXTKSEDINET:S100U7ZN
- ShareXTKSEDINET:S100T3E9
- ShareXTKSEDINET:S100T1SY
- ShareXTKSEDINET:S100SK4K
- ShareXTKSEDINET:S100SBFH
- ShareXTKSEDINET:S100RB43
14 of 14 declarations
About 株式会社M&A総研ホールディングス
M&A Research Institute Holdings, Inc. is a company specializing in mergers and acquisitions in the healthcare and pharmaceutical sector. It is listed on the XTKS market.
